Venture Kick — 2024 Investments
3 investments dated 2024 · listed companies and verified rows first · show all
8inks develops a multilayer curtain coating process for battery electrode manufacturing, enabling layered cell architectures in a single coating line to improve energy density, cycle life, and cost.
Advanced ManufacturingCleantechEnergy
Leon Baade(Founder)in
Co-investorsKickfundTeampact.venturesÜbermorgen VenturesAngel Investanother.vcFounderful
Amporin Pharmaceuticals develops small-molecule drugs targeting toxic membrane pores formed by misfolded protein oligomers to treat neurodegenerative diseases such as Parkinson's disease, Alzheimer's disease, and Type 2 diabetes.
AI & Machine LearningBiotechDeep TechBasel, CH
Kelvin Stott(CEO and Cofounder)inHervé Schaffhauser(CSO and Cofounder)inDaniel Umbricht(CMO and Cofounder)in
Co-investorsKickfund
Immunotherapies for T cell-mediated autoimmune conditions via modulation of coronin 1; spin-off from the University of Basel.
Rajesh Jayachandran, MD PhD(Founder)in
Co-investorsBioMedPartnersKickfund
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.